Table 2.
Summary of nutritional supplementation in the study cohort, stratified by type of micronutrient supplementation.
| Variables * | Mg Supplementation (n = 61) |
Ca+Mg+Zn Supplementation (n = 74) |
p-Value |
|---|---|---|---|
| Reason for supplementation | 0.594 | ||
| Self-medicated | 39 (63.9%) | 44 (59.5%) | |
| By recommendation | 22 (36.1%) | 30 (40.5%) | |
| Duration of supplementation | 0.266 | ||
| <9 months | 48 (78.7%) | 52 (70.3%) | |
| ≥9 months | 13 (21.3%) | 22 (29.7%) | |
| Other supplements used | |||
| Folate | 24 (39.3%) | 39 (52.7%) | 0.121 |
| Iron | 41 (67.2%) | 52 (70.3%) | 0.702 |
| Vitamin D | 18 (29.5%) | 24 (32.4%) | 0.714 |
| Probiotics | 14 (23.0%) | 21 (28.4%) | 0.473 |
| Consistency of intake | 0.852 | ||
| Daily | 39 (63.9%) | 45 (60.8%) | |
| At least 5 times a week | 18 (29.5%) | 25 (33.8%) | |
| Less than 5 times a week | 4 (6.6%) | 4 (5.4%) | |
| Form of magnesium | 0.967 | ||
| Mg(OH)2 | 6 (9.8%) | 6 (8.5%) | |
| MgO | 13 (21.3%) | 16 (22.5%) | |
| MgCl2 | 7 (11.5%) | 5 (7.0%) | |
| Lactate | 6 (9.8%) | 8 (11.3%) | |
| Citrate | 21 (34.4%) | 26 (36.6%) | |
| Aspartate | 8 (13.1%) | 10 (14.1%) | |
| Magnesium dose | 0.774 | ||
| <450 mg | 20 (32.8%) | 26 (35.1%) | |
| ≥450 mg | 41 (67.2%) | 48 (64.9%) |
* Data presented as n (frequency) unless specified differently.